Sohanya Roshan Cheng Karyopharm Therapeutics Inc. (KPTI) insider trading activity
Sohanya Roshan Cheng is EVP & Chief Commercial Officer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 404,051 shares of KPTI, which is worth approximately $315,159. The most recent transaction as insider was on Sep 04, 2024, when has been sold 5,356 shares (Common Stock) at a price of $0.72 per share, resulting in proceeds of $3,856. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
404K
2.68%
3M change
97.98%
12M change
Total Value Held
$315,159
Sohanya Roshan Cheng Transaction History
Also insider at
SRC
Sohanya Roshan Cheng
EVP & Chief Commercial Officer
Newton, MA